Variant report

Variant	esv3369555
Chromosome Location	chr17:38677926-38681324
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr17:38677633-38678334	A549	lung:	n/a	n/a
2	ATF3	chr17:38677477-38678404	A549	lung:	n/a	n/a
3	BCL3	chr17:38676937-38678422	A549	lung:	n/a	n/a
4	BCL3	chr17:38677511-38678395	A549	lung:	n/a	n/a
5	BRCA1	chr17:38677798-38678266	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr17:38677668-38678280	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr17:38677686-38678268	IMR90	lung:	n/a	n/a
8	CEBPB	chr17:38677556-38678433	A549	lung:	n/a	n/a
9	CEBPB	chr17:38677766-38678220	A549	lung:	n/a	n/a
10	CEBPB	chr17:38678680-38678798	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr17:38678562-38678931	IMR90	lung:	n/a	n/a
12	CHD2	chr17:38677630-38678258	Hela-S3	cervix:	n/a	n/a
13	CREB1	chr17:38677532-38678210	A549	lung:	n/a	n/a
14	CREB1	chr17:38677744-38678256	A549	lung:	n/a	n/a
15	CTCF	chr17:38679660-38679810	NHEK	skin:	n/a	n/a
16	E2F4	chr17:38677947-38678098	MCF10A-Er-Src	breast:	n/a	n/a
17	EGR1	chr17:38678233-38678661	K562	blood:	n/a	chr17:38678351-38678364 chr17:38678351-38678364 chr17:38678492-38678501 chr17:38678351-38678364 chr17:38678354-38678364 chr17:38678354-38678363 chr17:38678350-38678365
18	EGR1	chr17:38678239-38678466	K562	blood:	n/a	chr17:38678351-38678364 chr17:38678351-38678364 chr17:38678351-38678364 chr17:38678354-38678364 chr17:38678354-38678363 chr17:38678350-38678365
19	ELF1	chr17:38677519-38678305	A549	lung:	n/a	chr17:38677748-38677761
20	ELF1	chr17:38677503-38678170	A549	lung:	n/a	chr17:38677748-38677761
21	ELK1	chr17:38677596-38678248	Hela-S3	cervix:	n/a	n/a
22	EP300	chr17:38677393-38678459	A549	lung:	n/a	chr17:38677984-38677997
23	EP300	chr17:38678832-38679723	A549	lung:	n/a	n/a
24	EP300	chr17:38677793-38678297	Hela-S3	cervix:	n/a	chr17:38677984-38677997
25	EP300	chr17:38677436-38678470	ECC-1	luminal epithelium:	n/a	chr17:38677984-38677997
26	EP300	chr17:38677075-38678662	A549	lung:	n/a	chr17:38677984-38677997
27	EP300	chr17:38680870-38681291	HepG2	liver:	n/a	n/a
28	EP300	chr17:38677652-38678290	ECC-1	luminal epithelium:	n/a	chr17:38677984-38677997
29	ESR1	chr17:38677730-38678260	ECC-1	luminal epithelium:	n/a	chr17:38678001-38678016
30	ESR1	chr17:38677705-38678209	ECC-1	luminal epithelium:	n/a	chr17:38678001-38678016
31	ESR1	chr17:38677735-38678229	ECC-1	luminal epithelium:	n/a	chr17:38678001-38678016
32	ESR1	chr17:38677805-38678128	ECC-1	luminal epithelium:	n/a	chr17:38678001-38678016
33	ETS1	chr17:38677674-38678313	A549	lung:	n/a	n/a
34	FOS	chr17:38677689-38678299	MCF10A-Er-Src	breast:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
35	FOS	chr17:38677622-38678292	MCF10A-Er-Src	breast:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
36	FOS	chr17:38678564-38678900	MCF10A-Er-Src	breast:	n/a	n/a
37	FOS	chr17:38678559-38678927	MCF10A-Er-Src	breast:	n/a	n/a
38	FOS	chr17:38678677-38678891	MCF10A-Er-Src	breast:	n/a	n/a
39	FOS	chr17:38678675-38678913	MCF10A-Er-Src	breast:	n/a	n/a
40	FOS	chr17:38677668-38678297	MCF10A-Er-Src	breast:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
41	FOS	chr17:38677688-38678304	MCF10A-Er-Src	breast:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
42	FOSL2	chr17:38677269-38678529	A549	lung:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
43	FOSL2	chr17:38677597-38678303	A549	lung:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
44	FOSL2	chr17:38677483-38678363	SK-N-SH	brain:	n/a	chr17:38678116-38678126 chr17:38678117-38678125 chr17:38678116-38678127 chr17:38678116-38678126
45	FOXA1	chr17:38680767-38681314	HepG2	liver:	n/a	n/a
46	FOXA1	chr17:38680696-38681153	HepG2	liver:	n/a	n/a
47	FOXA1	chr17:38680762-38681261	HepG2	liver:	n/a	n/a
48	FOXA1	chr17:38680741-38681169	HepG2	liver:	n/a	n/a
49	FOXA2	chr17:38677582-38678316	A549	lung:	n/a	n/a
50	FOXA2	chr17:38680782-38681175	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:38677884-38677934	LNCaP	prostate:	n/a
2	chr17:38677884-38677934	Jurkat	blood:	n/a
3	chr17:38677884-38677934	HRPEpiC	eye:	n/a
4	chr17:38677884-38677934	HepG2	liver:	n/a
5	chr17:38677884-38677934	MCF10A-Er-Src	breast:	n/a
6	chr17:38677884-38677934	AG10803	skin:	n/a
7	chr17:38677884-38677934	HCPEpiC	choroid plexus:	n/a
8	chr17:38677884-38677934	ovcar-3	ovarian:	n/a
9	chr17:38677884-38677934	GM19239	blood:	n/a
10	chr17:38677884-38677934	AoSMC	blood vessel:	n/a
11	chr17:38677884-38677934	MCF-7	breast:	n/a
12	chr17:38677884-38677934	SK-N-MC	brain:	n/a
13	chr17:38677884-38677934	CMK	blood:	n/a
14	chr17:38677884-38677934	HEEpiC	esophagus:	n/a
15	chr17:38677884-38677934	HMEC	breast:	n/a
16	chr17:38677884-38677934	PANC-1	pancreas:	n/a
17	chr17:38677884-38677934	BE2_C	brain:	n/a
18	chr17:38677884-38677934	AG04450	lung:	fetal
19	chr17:38677884-38677934	K562	blood:	n/a
20	chr17:38677884-38677934	NHDF-neo	bronchial:	n/a
21	chr17:38677884-38677934	GM12891	blood:	n/a
22	chr17:38677884-38677934	GM06990	blood:	n/a
23	chr17:38677884-38677934	HEK293	kidney:	embryo
24	chr17:38677884-38677934	ProgFib	skin:	n/a
25	chr17:38677884-38677934	AG09309	skin:	n/a
26	chr17:38677884-38677934	NB4	blood:	n/a
27	chr17:38677884-38677934	NHBE	bronchial:	n/a
28	chr17:38677884-38677934	AG04449	skin:	fetal
29	chr17:38677884-38677934	BJ	skin:	n/a
30	chr17:38677884-38677934	SAEC	small airway:	n/a
31	chr17:38677884-38677934	HUVEC	blood vessel:	n/a
32	chr17:38677884-38677934	SK-N-SH	brain:	n/a
33	chr17:38677884-38677934	NT2-D1	testis:	n/a
34	chr17:38677884-38677934	H1-hESC	embryonic stem cell:	embryo
35	chr17:38677884-38677934	SK-N-SH_RA	brain:	n/a
36	chr17:38677884-38677934	A549	lung:	n/a
37	chr17:38677884-38677934	HCF	heart:	n/a
38	chr17:38677884-38677934	U87	brain:	n/a
39	chr17:38677884-38677934	PFSK-1	brain:	n/a
40	chr17:38677884-38677934	Hepatocyte	liver:	n/a
41	chr17:38677884-38677934	HCM	heart:	n/a
42	chr17:38677884-38677934	AG09319	gingival:	n/a
43	chr17:38677884-38677934	PrEC	prostate:	n/a
44	chr17:38677884-38677934	GM12878	blood:	n/a
45	chr17:38677884-38677934	HIPEpiC	eye:	n/a
46	chr17:38677884-38677934	T-47D	breast:	n/a
47	chr17:38677884-38677934	HAEpiC	amniotic membrane:	n/a
48	chr17:38677884-38677934	GM12892	blood:	n/a
49	chr17:38677884-38677934	Hela-S3	cervix:	n/a
50	chr17:38677884-38677934	HCT-116	colon:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:38677625..38680142-chr17:38696757..38698899,2	MCF-7	breast:
2	chr17:38671928..38674313-chr17:38677766..38679421,2	MCF-7	breast:
3	chr17:38676381..38678576-chr17:38679743..38681770,2	K562	blood:
4	chr17:38678096..38679987-chr17:38715270..38716866,2	MCF-7	breast:
5	chr17:38569801..38571878-chr17:38675987..38678508,2	K562	blood:
6	chr17:38679491..38681189-chr17:38685861..38688027,2	MCF-7	breast:
7	chr17:38647398..38649761-chr17:38676727..38678938,2	K562	blood:
8	chr17:38673127..38676333-chr17:38678075..38682047,4	K562	blood:
9	chr17:38676381..38678576-chr17:38679743..38681770,2	K562	blood:
10	chr17:38639539..38641673-chr17:38677366..38679503,2	K562	blood:
11	chr17:38677974..38679924-chr17:38691519..38693332,2	MCF-7	breast:
12	chr17:38676325..38680650-chr17:38704875..38709448,7	MCF-7	breast:
13	chr17:38600130..38602545-chr17:38675909..38679796,4	MCF-7	breast:
14	chr17:38654640..38659414-chr17:38673768..38679140,6	MCF-7	breast:
15	chr17:38629814..38633387-chr17:38676751..38679736,4	MCF-7	breast:
16	chr17:38571667..38573665-chr17:38677679..38680655,2	K562	blood:
17	chr17:38675352..38677497-chr17:38677864..38681564,3	MCF-7	breast:
18	chr17:38474075..38478371-chr17:38679567..38683859,4	MCF-7	breast:
19	chr17:38676796..38678412-chr17:38763235..38765302,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IGFBP4-1	chr17:38679608-38679907	NONHSAT053554
2	lnc-IGFBP4-1	chr17:38679552-38679907	XLOC_012197

Variant related genes	Relation type
ENSG00000266088	TF binding region
ENSG00000266088	CpG island
ENSG00000266088	chromatin interactions
ENSG00000131746	chromatin interactions
ENSG00000131759	chromatin interactions

Extended variants
information (count: 123 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:123 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs533798105	chr17:38677939-38677940	Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs555034833	chr17:38678014-38678015	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs73983072	chr17:38678028-38678029	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs73310959	chr17:38678043-38678044	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs555979151	chr17:38678059-38678060	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs71152678	chr17:38678074-38678075	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs8077724	chr17:38678106-38678107	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs144663297	chr17:38678158-38678159	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs191261031	chr17:38678169-38678170	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs112847367	chr17:38678170-38678171	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs572417569	chr17:38678174-38678175	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs543032579	chr17:38678254-38678255	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs561104148	chr17:38678255-38678256	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs148510442	chr17:38678356-38678357	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs373775860	chr17:38678361-38678362	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs544119137	chr17:38678372-38678373	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs565528049	chr17:38678420-38678421	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs375581050	chr17:38678442-38678443	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs532761063	chr17:38678455-38678456	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs56290320	chr17:38678484-38678485	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs71152679	chr17:38678486-38678487	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs111995867	chr17:38678488-38678489	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs151062075	chr17:38678490-38678491	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs372143199	chr17:38678491-38678492	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs73983073	chr17:38678492-38678493	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs111578513	chr17:38678493-38678494	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs73983074	chr17:38678494-38678495	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs548993994	chr17:38678495-38678496	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs567140251	chr17:38678498-38678499	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs116061849	chr17:38678517-38678518	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs139818064	chr17:38678526-38678527	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs35294714	chr17:38678549-38678550	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs184642929	chr17:38678617-38678618	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs573613220	chr17:38678634-38678635	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs187956554	chr17:38678658-38678659	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs35909561	chr17:38678701-38678702	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs192963188	chr17:38678746-38678747	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs572534325	chr17:38678776-38678777	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs144391631	chr17:38678781-38678782	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs559601059	chr17:38678808-38678809	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs374508757	chr17:38678811-38678812	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs147830803	chr17:38678821-38678822	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs576356504	chr17:38678837-38678838	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs543793101	chr17:38678868-38678869	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs202007556	chr17:38678885-38678886	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs530012523	chr17:38678911-38678912	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs565591288	chr17:38678918-38678919	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs141405758	chr17:38678930-38678931	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs117897189	chr17:38678947-38678948	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs559675434	chr17:38678991-38678992	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:120)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastric cancer	24379144	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16620391	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Urothelial carcinoma	21177765	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Disease	22962312	CNVD
Mental retardation	20152051	CNVD
Mental retardation	19951919	CNVD
Mental retardation	22817714	CNVD
Mental retardation	21956041	CNVD
Brain cancer	19584924	CNVD
Glioblastoma multiforme	22286061	CNVD
Schizophrenia	21399695	CNVD
Non-syndromic sensorineural hearing loss	19165922	CNVD
Prader-willi syndrome	20588305	CNVD
17q21.31 microdeletion syndrome	16940994	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
17q21.31 microdeletion syndrome	22283845	CNVD
Intellectual disability	22194194	CNVD
17q21.31 microdeletion syndrome	20606400	CNVD
17q21.31 microdeletion syndrome	18628315	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Human papillomavirus	17975027	CNVD
Breast cancer	19767729	CNVD
Breast cancer	20409316	CNVD
Medulloblastoma	16783165	CNVD
Bladder cancer	21909424	CNVD
Intracranial arachnoid cysts	20187927	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:140 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:38668400-38680600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr17:38671400-38679800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr17:38671600-38679400	Enhancers	Placenta	Placenta
4	chr17:38672200-38679200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr17:38672600-38680800	Enhancers	Placenta Amnion	Placenta Amnion
6	chr17:38672800-38679200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr17:38673600-38678200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
8	chr17:38673800-38678200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
9	chr17:38674000-38679200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
10	chr17:38674200-38681200	Enhancers	Breast Myoepithelial Primary Cells	Breast
11	chr17:38674600-38678000	Weak transcription	Thymus	Thymus
12	chr17:38675000-38679400	Enhancers	Primary T cells fromperipheralblood	blood
13	chr17:38675400-38679200	Enhancers	Primary T helper cells PMA-I stimulated	--
14	chr17:38675400-38680800	Enhancers	HMEC	breast
15	chr17:38675600-38686600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
16	chr17:38675800-38679200	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
17	chr17:38676200-38678000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
18	chr17:38676800-38678200	Strong transcription	Primary B cells from peripheral blood	blood
19	chr17:38677000-38678000	Enhancers	HSMM	muscle
20	chr17:38677000-38678200	Enhancers	ES-I3 Cell Line	embryonic stem cell
21	chr17:38677000-38678400	Enhancers	NHLF	lung
22	chr17:38677000-38679000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
23	chr17:38677000-38679200	Enhancers	HSMMtube	muscle
24	chr17:38677000-38679600	Enhancers	Dnd41	blood
25	chr17:38677000-38680800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr17:38677200-38678000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr17:38677200-38678000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr17:38677200-38678000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr17:38677200-38678400	Flanking Active TSS	Hela-S3	cervix
30	chr17:38677200-38678400	Enhancers	NHDF-Ad	bronchial
31	chr17:38677200-38678600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr17:38677200-38678600	Enhancers	NH-A	brain
33	chr17:38677200-38678800	Enhancers	Osteobl	bone
34	chr17:38677200-38679800	Enhancers	Esophagus	oesophagus
35	chr17:38677400-38678200	Enhancers	Fetal Thymus	thymus
36	chr17:38677400-38678400	Flanking Active TSS	A549	lung
37	chr17:38677400-38678600	Enhancers	Primary T helper naive cells from peripheral blood	blood
38	chr17:38677400-38678600	Enhancers	K562	blood
39	chr17:38677400-38679200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr17:38677400-38679200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr17:38677400-38679800	Weak transcription	Primary B cells from cord blood	blood
42	chr17:38677600-38678000	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
43	chr17:38677600-38678000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr17:38677600-38678200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr17:38677600-38678400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr17:38677600-38678800	Flanking Active TSS	NHEK	skin
47	chr17:38677600-38682200	Weak transcription	Spleen	Spleen
48	chr17:38677600-38687800	Weak transcription	Right Ventricle	heart
49	chr17:38677800-38678000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
50	chr17:38677800-38678000	Flanking Active TSS	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links